2020
DOI: 10.1101/2020.09.30.321398
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Novel genetic tools to model functional enzyme restoration in succinic semialdehyde dehydrogenase deficiency (SSADHD)

Abstract: SSADHD is a rare inborn metabolic disorder caused by the functional impairment of SSADH (encoded by the aldh5a1 gene), an enzyme essential for breaking down the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). In SSADHD, pathologic accumulation of GABA results in broad spectrum encephalopathy including developmental delay, ataxia, seizures and a risk of sudden unexpected death in epilepsy (SUDEP). Proof-of-concept systemic SSADH restoration via enzyme replacement therapy (ERT) or aldh5a1 gene transf… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 37 publications
(41 reference statements)
0
1
0
Order By: Relevance
“…Further studies using murine SSADHD models to correlate transcranial magnetic stimulation data with immunohistochemical and electrophysiologic data will be useful to better elucidate this inconsistency. 5,31,32…”
Section: Discussionmentioning
confidence: 99%
“…Further studies using murine SSADHD models to correlate transcranial magnetic stimulation data with immunohistochemical and electrophysiologic data will be useful to better elucidate this inconsistency. 5,31,32…”
Section: Discussionmentioning
confidence: 99%